http://rdf.ncbi.nlm.nih.gov/pubchem/patent/YU-20097-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-1804 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C401-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C401-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18 |
| filingDate | 1997-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_058b77962cd5fe7d56206352dfa0ecae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de097e32910c554f01f878846aa4a8f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_633fb3a6828b853cfa16aaf36af3675f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a650b971f049f4beb96dc11dee95b62 |
| publicationDate | 1999-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | YU-20097-A |
| titleOfInvention | FLUATED ANALYSIS OF VITAMIN D3, INTERMEDIATES FOR THEIR OBTAINING, A PROCEDURE FOR OBTAINING SUCH FLAMORATED ANALYSIS OF VITAMIN D3, A PHARMACEUTICAL MIXTURE CONTAINING ANALOGUE OF FLUORATED VITAMIN D3 AND |
| abstract | Mine fluorinated analogues of Vitamin D3 of the formula in which X (H, H) or = CH2, R1 and R2 are independently hydrogen, (C1-C4) -alkyl or -fluoroalkyl, or R1 and R2 together with C-20 form (C3-C6) -cycloalkyl or -cyclofluoroalkyl, or R1 and R2 together form = CH2, R3 and R4 independently of one another, (C1-C4) -alkyl or fluoroalkyl, or R3 and R4 together with C-25 form (C3-C9) -cycloalkyl or -cyclofluoroalkyl, A simple or double bond, and B double or triple bond, except (i) when X is = CH2, R3 and R4 are each CF3, A is a double bond and one of R1 or R2 is hydrogen, then the other of R1 or R2 cannot be CH3, (ii) when X is = CH2, R3 and R4 are each (C1-C2) -alkyl, A is a double bond and R2 is hydrogen, then R1 cannot be CH3, (iii) when X is = CH2, R3 and R4 are each (C1-C4) -alkyl, A is a double bond and R1 is hydrogen, then R2 cannot be CH3, (iv) when X is = CH2. one of R3 or R4 is CF3, A is a double bond, R1 is CH3 and R2 is hydrogen, then the other of R3 or R4 cannot be CH3, and (v) when X is hydrogen, R3 and R4 are each CF3, A is a double bond, B is a triple bond and R2 is hydrogen, then R1 cannot be CH3, and the compounds of Formula I above in which X is (H, H) or = CH2, R1 and R2 are, independently of one another, hydrogen, (C1-C4) -alkyl or -fluoroalkyl, or R1 and R2 together with C-20 form (C3-C6 ) -cycloalkyl or -cyclofluoroalkyl, or R1 and R2 together form = CH2, R3 and R4 are, independently of one another, (C1-C4) -alkyl or -fluoroalkyl, or R3 and R4 together with C-25 form (C3- C9) -cycloalkyl or -cyclofluoroalkyl, A is a simple or double bond, and B is a double or triple bond, except when R3 and R4 are each CF3 and A is a double bond and B is a triple bond and R2 is hydrogen, then R1 cannot be CH3, are used in the treatment of osteoporosis. |
| priorityDate | 1996-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.